Sowmya Viswanathan

Without new funding, key part of Canada’s stem cell research ecosystem to close

• Health care in Canada sits upon a precipice. We are faced with a looming crisis as costs for degenerative disease nears $200-billion each year

Opinion | BY CINDI MORSHEAD, SOWMYA VISWANATHAN | February 20, 2019

Without new funding, key part of Canada’s stem cell research ecosystem to close

Opinion | BY CINDI MORSHEAD, SOWMYA VISWANATHAN | February 20, 2019

• Health care in Canada sits upon a precipice. We are faced with a looming crisis as costs for degenerative disease nears $200-billion each year

Without new funding, key part of Canada’s stem cell research ecosystem to close

Opinion | BY CINDI MORSHEAD, SOWMYA VISWANATHAN | February 20, 2019

• Health care in Canada sits upon a precipice. We are faced with a looming crisis as costs for degenerative disease nears $200-billion each year

Without new funding, key part of Canada’s stem cell research ecosystem to close

• Health care in Canada sits upon a precipice. We are faced with a looming crisis as costs for degenerative disease nears $200-billion each year

Opinion | BY CINDI MORSHEAD, SOWMYA VISWANATHAN | February 20, 2019

Without new funding, key part of Canada’s stem cell research ecosystem to close

Opinion | BY CINDI MORSHEAD, SOWMYA VISWANATHAN | February 20, 2019

• Health care in Canada sits upon a precipice. We are faced with a looming crisis as costs for degenerative disease nears $200-billion each year

Without new funding, key part of Canada’s stem cell research ecosystem to close

Opinion | BY CINDI MORSHEAD, SOWMYA VISWANATHAN | February 20, 2019

• Health care in Canada sits upon a precipice. We are faced with a looming crisis as costs for degenerative disease nears $200-billion each year

More Stories